Characteristics and evolution of 38 patients with rheumatic diseases and COVID-19 under DMARD therapy

Clin Rheumatol. 2021 Mar;40(3):1197-1199. doi: 10.1007/s10067-020-05510-9. Epub 2020 Nov 24.

Affiliations

¹ Servicio de Reumatología, Hospital Universitario, Universidad Autónoma de Nuevo León, Av. Gonzalitos No. 235 Nte. Col. Mitras Centro, C.P. 64460, Monterrey, NL, México. [email protected].
² Servicio de Reumatología, Hospital Universitario, Universidad Autónoma de Nuevo León, Av. Gonzalitos No. 235 Nte. Col. Mitras Centro, C.P. 64460, Monterrey, NL, México.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Antirheumatic Agents / therapeutic use*
COVID-19 / complications
COVID-19 / therapy*
Female
Humans
Male
Mexico
Middle Aged
Rheumatic Diseases / complications
Rheumatic Diseases / drug therapy*
Treatment Outcome
Young Adult

Substances

Antirheumatic Agents